SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals

BSE: 500660|NSE: GLAXO|ISIN: INE159A01016|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 30, 16:01
3575.60
76.7 (2.19%)
VOLUME 827
LIVE
NSE
May 30, 16:01
3572.25
43.9 (1.24%)
VOLUME 5,264
News on GlaxoSmithKline Pharmaceuticals
Select Year: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
GlaxoSmithKline Pharmaceuticals: Outcome of board meeting

9.49 pm | 26 May 2016 |  Source: Moneycontrol.com

GlaxoSmithKline Pharmaceuticals in its meeting held on May 25, 2016, re-appointed Mr. Raju Krishnaswamy as whole- time Director of the Company for per...

GlaxoSmithKline Pharma March quarter net at Rs 106 cr

9.10 am | 26 May 2016 |  Source: PTI

The company had posted a net profit of Rs 102.85 crore for the same period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a filing to...

GlaxoSmithKline Pharmaceuticals recommends dividend

3.15 pm | 25 May 2016 |  Source: Moneycontrol.com

GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2016, has recommended a...

Stocks that should be on your radar 

8.48 am | 12 May 2016 |  Source: CNBC-TV18

Dr Reddy's Laboratories: Dr Reddy's Laboratories Q4 earning today. Setback for Dr Reddy's Laboratories as DRL, Teva lose bid on Mozobil patent. Mozobi...

GlaxoSmithKline Pharmaceuticals FY16 results on May 25, 2016

10.14 pm | 04 May 2016 |  Source: Moneycontrol.com

GlaxoSmithKline Pharmaceuticals' board meeting will be held on May 25, 2016, to consider, approval of audited financial results (Standalone & Consolid...

Snapdeal ropes in ex-HUL exec Kanika Kalra as VP Marketing

2.40 pm | 26 Apr 2016 |  Source: PTI

With over 12 years of experience, Kalra joins Snapdeal after stints at Hindustan Unilever Ltd, GlaxoSmithKline Consumer Healthcare Ltd and Pepsico, Sn...

Sell GlaxoSmithKline; target of Rs 2450: Axis Securities

12.38 pm | 18 Feb 2016 |  Source: Moneycontrol.com

Axis Securities is bearish on GlaxoSmithKline and has recommended sell rating on the stock with a target price of Rs 2450 in its research report dated...

GlaxoSmithKline Pharma Q3 net up 76% at Rs 80 cr

6.56 pm | 10 Feb 2016 |  Source: PTI

Net sales of the company rose to Rs 728.70 crore in the October-December quarter this fiscal, from Rs 646.15 crore in the same period of previous year...

Cos margins to outperform industry avg this fiscal: GSK Pharma 

5.00 pm | 10 Feb 2016 |  Source: CNBC-TV18

In an interview with CNBC-TV18, A Vaidheesh, VP, South Asia and MD of India GSK said that company’s growth is in-line with the market and expects ma...

1 2
Quick Links for GlaxoSmithKline Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.